Phosphoproteomics and molecular cardiology: Techniques, applications and challenges

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 3, 2012, Pages 354-368

  Sun, Zeyu ^a   Hamilton, Karyn L ^b   Reardon, Kenneth F ^a,b  

^a Engineering Research Center and Hydraulics Laboratory   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Mass spectrometry; Molecular cardiology; Phosphopeptide enrichment; Phosphoproteomics; Phosphorylation

Indexed keywords

PHOSPHOPEPTIDE; PROTEIN KINASE C; TROPONIN T;

AFFINITY CHROMATOGRAPHY; CARDIOLOGY; CARDIOMYOPATHY; CATION EXCHANGE; COLLISIONALLY ACTIVATED DISSOCIATION; DISSOCIATION; ELECTRON TRANSFER DISSOCIATION; ELECTRON TRANSPORT; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HIGH THROUGHPUT SCREENING; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; METAL OXIDE AFFINITY CHROMATOGRAPHY; MOLECULAR CARDIOLOGY; MULTIDIMENSIONAL LIQUID CHROMATOGRAPHY; NONHUMAN; PHOSPHOPROTEOMICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE PHOSPHOPROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; STRONG CATION EXCHANGE; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS;

ALGORITHMS; ANIMALS; HUMANS; MYOCARDIUM; PHOSPHOPROTEINS; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84864821845     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.06.001     Document Type: Review

References (242)

1. Zhang H., Zha X.M., Tan Y., Hornbeck P.V., Mastrangelo A.J., Alessi D.R., et al. Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. J Biol Chem 2002, 277(42):39379-39387.
2. Kalume D.E., Molina H., Pandey A. Tackling the phosphoproteome: tools and strategies. Curr Opin Chem Biol 2003, 7(1):64-69.
3. Seet B.T., Dikic I., Zhou M.M., Pawson T. Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol 2006, 7(7):473-483.
4. Anderson M.E., Higgins L.S., Schulman H. Disease mechanisms and emerging therapies: protein kinases and their inhibitors in myocardial disease. Nat Clin Pract Cardiovasc Med 2006, 3(8):437-445.
5. Lorenz K., Schmitt J.P., Vidal M., Lohse M.J. Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling. Int J Biochem Cell Biol 2009, 41(12):2351-2355.
6. Huber L.A., Pfaller K., Vietor I. Organelle proteomics - implications for subcellular fractionation in proteomics. Circ Res 2003, 92(9):962-968.
7. Trost M., Bridon G., Desjardins M., Thibault P. Subcellular phosphoproteomics. Mass Spectrom Rev 2010, 29(6):962-990.
8. Hoffert J.D., Knepper M.A. Taking aim at shotgun phosphoproteomics. Anal Biochem 2008, 375(1):1-10.
9. Bodzon-Kulakowska A., Bierczynska-Krzysik A., Dylag T., Drabik A., Suder P., Noga M., et al. Methods for samples preparation in proteomic research. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 849(1-2):1-31.
10. Hagen J. Proteomics sample preparation 2008, Wiley-VCH.
11. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975, 250(10):4007-4021.
12. Steinberg T.H. Protein gel staining methods: an introduction and overview. Methods Enzymol 2009, 463:541-563.
13. Thingholm T.E., Jensen O.N., Larsen M.R. Analytical strategies for phosphoproteomics. Proteomics 2009, 9(6):1451-1468.
14. Reinders J., Sickmann A. State-of-the-art in phosphoproteomics. Proteomics 2005, 5(16):4052-4061.
15. Morandell S., Stasyk T., Grosstessner-Hain K., Roitinger E., Mechtler K., Bonn G.K., et al. Phosphoproteomics strategies for the functional analysis of signal transduction. Proteomics 2006, 6(14):4047-4056.
16. Bendt A.K., Burkovski A., Schaffer S., Bott M., Farwick M., Hermann T. Towards a phosphoproteome map of Corynebacterium glutamicum. Proteomics 2003, 3(8):1637-1646.
17. Kaufmann H., Bailey J.E., Fussenegger M. Use of antibodies for detection of phosphorylated proteins separated by two-dimensional gel electrophoresis. Proteomics 2001, 1(2):194-199.
18. Mandell J.W. Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology. Am J Pathol 2003, 163(5):1687-1698.
19. Schwertz H., Carter J.M., Abdudureheman M., Russ M., Buerke U., Schlitt A., et al. Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitor. Proteomics 2007, 7(24):4579-4588.
20. Steinberg T.H., Agnew B.J., Gee K.R., Leung W.-Y., Goodman T., Schulenberg B., et al. Global quantitative phosphoprotein analysis using multiplexed proteomics technology. Proteomics 2003, 3(7):1128-1144.
21. Schulenberg B., Goodman T.N., Aggeler R., Capaldi R.A., Patton W.F. Characterization of dynamic and steady-state protein phosphorylation using a fluorescent phosphoprotein gel stain and mass spectrometry. Electrophoresis 2004, 25(15):2526-2532.
22. Hopper R.K., Carroll S., Aponte A.M., Johnson D.T., French S., Shen R.F., et al. Mitochondrial matrix phosphoproteome: Effect of extra mitochondrial calcium. Biochemistry 2006, 45(8):2524-2536.
23. Aponte A.M., Phillips D., Hopper R.K., Johnson D.T., Harris R.A., Blinova K., et al. Use of P-32 to study dynamics of the mitochondrial phosphoproteome. J Proteome Res 2009, 8(6):2679-2695.
24. Kinoshita E., Kinoshita-Kikuta E., Takiyama K., Koike T. Phosphate-binding tag, a new tool to visualize phosphorylated proteins. Mol Cell Proteomics 2006, 5(4):749-757.
25. Santoni V., Molloy M., Rabilloud T. Membrane proteins and proteomics: un amour impossible?. Electrophoresis 2000, 21(6):1054-1070.
26. Opiteck G.J., Lewis K.C., Jorgenson J.W., Anderegg R.J. Comprehensive on-line LC/LC/MS of proteins. Anal Chem 1997, 69(8):1518-1524.
27. Wu C.C., MacCoss M.J. Shotgun proteomics: tools for the analysis of complex biological systems. Curr Opin Mol Ther 2002, 4(3):242-250.
28. Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001, 19(3):242-247.
29. Motoyama A., Yates J.R. Multidimensional LC separations in shotgun proteomics. Anal Chem 2008, 80(19):7187-7193.
30. Fournier M.L., Gilmore J.M., Martin-Brown S.A., Washburn M.P. Multidimensional separations-based shotgun proteomics. Chem Rev 2007, 107(8):3654-3686.
31. Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villén J., Li J., et al. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci U S A 2004, 101(33):12130-12135.
32. Lim K.B., Kassel D.B. Phosphopeptides enrichment using on-line two-dimensional strong cation exchange followed by reversed-phase liquid chromatography/mass spectrometry. Anal Biochem 2006, 354(2):213-219.
33. Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., et al. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci U S A 2004, 101(33):12130-12135.
34. 2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster. J Proteome Res 2008, 7(2):687-697.
35. Wu J.A., Warren P., Shakey Q., Sousa E., Hill A., Ryan T.E., et al. Integrating titania enrichment, iTRAQ labeling, and Orbitrap CID-HCD for global identification and quantitative analysis of phosphopeptides. Proteomics 2010, 10(11):2224-2234.
36. Villén J., Beausoleil S.A., Gerber S.A., Gygi S.P. Large-scale phosphorylation analysis of mouse liver. Proc Natl Acad Sci U S A 2007, 104(5):1488-1493.
37. Gruhler A., Olsen J.V., Mohammed S., Mortensen P., Færgeman N.J., Mann M., et al. Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway. Mol Cell Proteomics 2005, 4(3):310-327.
38. Villen J., Gygi S.P. The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry. Nat Protoc 2008, 3(10):1630-1638.
39. Dephoure N., Gygi S.P. A solid phase extraction-based platform for rapid phosphoproteomic analysis. Methods 2011, 54(4):379-386.
40. Han G.H., Ye M.L., Zhou H.J., Jiang X.N., Feng S., Jiang X.G., et al. Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography. Proteomics 2008, 8(7):1346-1361.
41. Dai J., Wang L.S., Wu Y.B., Sheng Q.H., Wu J.R., Shieh C.H., et al. Fully automatic separation and identification of phosphopeptides by continuous pH-gradient anion exchange online coupled with reversed-phase liquid chromatography mass spectrometry. J Proteome Res 2009, 8(1):133-141.
42. Wang F.J., Han G.H., Yu Z.Y., Jiang X.N., Sun S.T., Chen R., et al. Fractionation of phosphopeptides on strong anion-exchange capillary trap column for large-scale phosphoproteome analysis of microgram samples. J Sep Sci 2010, 33(13):1879-1887.
43. Nühse T.S., Stensballe A., Jensen O.N., Peck S.C. Large-scale analysis of in vivo phosphorylated membrane proteins by immobilized metal ion affinity chromatography and mass spectrometry. Mol Cell Proteomics 2003, 2(11):1234-1243.
44. Nie S., Dai J., Ning Z.B., Cao X.J., Sheng Q.H., Zeng R. Comprehensive profiling of phosphopeptides based on anion exchange followed by flow-through enrichment with titanium dioxide (AFET). J Proteome Res 2010, 9(9):4585-4594.
45. Dai J., Jin W.H., Sheng Q.H., Shieh C.H., Wu J.R., Zeng R. Protein phosphorylation and expression profiling by yin-yang multidimensional liquid chromatography (Yin-yang MDLC) mass spectrometry. J Proteome Res 2007, 6(1):250-262.
46. Motoyama A., Xu T., Ruse C.I., Wohlschlegel J.A., Yates J.R. Anion and cation mixed-bed ion exchange for enhanced multidimensional separations of peptides and phosphopeptides. Anal Chem 2007, 79(10):3623-3634.
47. Alpert A.J. Hydrophilic-interaction chromatography for the separation of peptides, nucleic-acids and other polar compounds. J Chromatogr 1990, 499:177-196.
48. McNulty D.E., Annan R.S. Hydrophilic interaction chromatography reduces the complexity of the phosphoproteome and improves global phosphopeptide isolation and detection. Mol Cell Proteomics 2008, 7(5):971-980.
49. Wu C.-J., Chen Y.-W., Tai J.-H., Chen S.-H. Quantitative phosphoproteomics studies using stable isotope dimethyl labeling coupled with IMAC-HILIC-nanoLC/MS/MS for estrogen-induced transcriptional regulation. J Proteome Res 2011, 10(3):1088-1097.
50. Saleem R.A., Aitchison J.D. Quantitative phosphoproteomics in fatty acid stimulated Saccharomyces cerevisiae. J Vis Exp 2009, 32:1474.
51. McNulty D.E., Annan R.S. Hydrophilic interaction chromatography for fractionation and enrichment of the phosphoproteome. Methods Mol Biol 2009, 527:93-105.
52. Singer D., Kuhlmann J., Muschket M., Hoffmann R. Separation of multiphosphorylated peptide isomers by hydrophilic interaction chromatography on an aminopropyl phase. Anal Chem 2010, 82(15):6409-6414.
53. Saleem R.A., Rogers R.S., Ratushny A.V., Dilworth D.J., Shannon P.T., Shteynberg D., et al. Integrated phosphoproteomics analysis of a signaling network governing nutrient response and peroxisome induction. Mol Cell Proteomics 2010, 9(9):2076-2088.
54. 2 for the in-depth analysis of the serum proteome and phosphoproteome: application to clinical sera derived from humans with benign prostate hyperplasia. Anal Chem 2011, 83(3):708-718.
55. Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H. A multidimensional chromatography technology for in-depth phosphoproteome analysis. Mol Cell Proteomics 2008, 7(7):1389-1396.
56. Boja E.S., Phillips D., French S.A., Harris R.A., Balaban R.S. Quantitative mitochondrial phosphoproteomics using iTRAQ on an LTQ-Orbitrap with high energy collision dissociation. J Proteome Res 2009, 8(10):4665-4675.
57. Gilar M., Olivova P., Daly A.E., Gebler J.C. Orthogonality of separation in two-dimensional liquid chromatography. Anal Chem 2005, 77(19):6426-6434.
58. Zhang H., Guo T., Li X., Datta A., Park J.E., Yang J., et al. Simultaneous characterization of glyco- and phosphoproteomes of mouse brain membrane proteome with electrostatic repulsion hydrophilic interaction chromatography. Mol Cell Proteomics 2010, 9(4):635-647.
59. Gan C.S., Guo T., Zhang H., Lim S.K., Sze S.K. A comparative study of electrostatic repulsion-hydrophilic interaction chromatography (ERLIC) versus SCX-IMAC-based methods for phosphopeptide isolation/enrichment. J Proteome Res 2008, 7(11):4869-4877.
60. Alpert A.J. Electrostatic repulsion hydrophilic interaction chromatography for isocratic separation of charged solutes and selective isolation of phosphopeptides. Anal Chem 2008, 80(1):62-76.
61. 2 for global phosphoproteomics approaches. J Proteome Res 2011, 10(8):3474-3483.
62. Chen W.G., White F.M. Proteomic analysis of cellular signaling. Expert Rev Proteomics 2004, 1(3):343-354.
63. Yan G.R., Xiao C.L., He G.W., Yin X.F., Chen N.P., Cao Y., et al. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways. Proteomics 2010, 10(5):976-986.
64. Steen H., Kuster B., Fernandez M., Pandey A., Mann M. Tyrosine phosphorylation mapping of the epidermal growth factor receptor signaling pathway. J Biol Chem 2002, 277(2):1031-1039.
65. Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 2005, 23(1):94-101.
66. Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P. Large-scale phosphorylation analysis of mouse liver. Proc Natl Acad Sci U S A 2007, 104(5):1488-1493.
67. Collins M.O., Yu L., Choudhary J.S. Analysis of protein phosphorylation on a proteome-scale. Proteomics 2007, 7(16):2751-2768.
68. Muszynska G., Dobrowolska G., Medin A., Ekman P., Porath J.O. Model studies on iron(III) ion affinity-chromatography. II. Interaction of immobilized iron(III) ions with phosphorylated amino-acids, peptides and proteins. J Chromatogr 1992, 604(1):19-28.
69. 3+) affinity chromatography. Anal Biochem 1986, 154(1):250-254.
70. Posewitz M.C., Tempst P. Immobilized gallium(III) affinity chromatography of phosphopeptides. Anal Chem 1999, 71(14):2883-2892.
71. Coletti-Previero M.A., Previero A. Alumina-phosphate complexes for immobilization of biomolecules. Anal Biochem 1989, 180(1):1-10.
72. Feng S., Ye M., Zhou H., Jiang X., Jiang X., Zou H., et al. Immobilized zirconium ion affinity chromatography for specific enrichment of phosphopeptides in phosphoproteome analysis. Mol Cell Proteomics 2007, 6(9):1656-1665.
73. 4+ affinity chromatography microspheres for specific enrichment of phosphopeptides. Anal Chim Acta 2009, 636(1):34-41.
74. Ficarro S.B., McCleland M.L., Stukenberg P.T., Burke D.J., Ross M.M., Shabanowitz J., et al. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol 2002, 20(3):301-305.
75. 18O labeling: a tool for proteomics. Rapid Commun Mass Spectrom 2001, 15(24):2456-2465.
76. Jensen S.S., Larsen M.R. Evaluation of the impact of some experimental procedures on different phosphopeptide enrichment techniques. Rapid Commun Mass Spectrom 2007, 21(22):3635-3645.
77. Nousiainen M., Sillje H.H., Sauer G., Nigg E.A., Korner R. Phosphoproteome analysis of the human mitotic spindle. Proc Natl Acad Sci U S A 2006, 103(14):5391-5396.
78. Sano A., Nakamura H. Titania as a chemo-affinity support for the column-switching HPLC analysis of phosphopeptides: application to the characterization of phosphorylation sites in proteins by combination with protease digestion and electrospray ionization mass spectrometry. Anal Sci 2004, 20(5):861-864.
79. Sano A., Nakamura H. Chemo-affinity of titania for the column-switching HPLC analysis of phosphopeptides. Anal Sci 2004, 20(3):565-566.
80. Aryal U.K., Ross A.R. Enrichment and analysis of phosphopeptides under different experimental conditions using titanium dioxide affinity chromatography and mass spectrometry. Rapid Commun Mass Spectrom 2010, 24(2):219-231.
81. Gates M.B., Tomer K.B., Deterding L.J. Comparison of metal and metal oxide media for phosphopeptide enrichment prior to mass spectrometric analyses. J Am Soc Mass Spectrom 2010, 21(10):1649-1659.
82. Leitner A., Sturm M., Hudecz O., Mazanek M., Smatt J.H., Linden M., et al. Probing the phosphoproteome of HeLa cells using nanocast metal oxide microspheres for phosphopeptide enrichment. Anal Chem 2010, 82(7):2726-2733.
83. Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127(3):635-648.
84. Macek B., Mijakovic I., Olsen J.V., Gnad F., Kumar C., Jensen P.R., et al. The serine/threonine/tyrosine phosphoproteome of the model bacterium Bacillus subtilis. Mol Cell Proteomics 2007, 6(4):697-707.
85. Larsen M.R., Thingholm T.E., Jensen O.N., Roepstorff P., Jorgensen T.J. Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol Cell Proteomics 2005, 4(7):873-886.
86. Wolschin F., Wienkoop S., Weckwerth W. Enrichment of phosphorylated proteins and peptides from complex mixtures using metal oxide/hydroxide affinity chromatography (MOAC). Proteomics 2005, 5(17):4389-4397.
87. Pinkse M.W., Uitto P.M., Hilhorst M.J., Ooms B., Heck A.J. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Anal Chem 2004, 76(14):3935-3943.
88. Ikeguchi Y., Nakamura H. Determination of organic phosphates by column-switching high performance anion-exchange chromatography using on-line preconcentration on titania. Anal Sci 1997, 13(3):479-483.
89. Zhou H.J., Tian R.J., Ye M.L., Xu S.Y., Feng S., Pan C.S., et al. Highly specific enrichment of phosphopeptides by zirconium dioxide nanoparticles for phosphoproteome analysis. Electrophoresis 2007, 28(13):2201-2215.
90. Shin E.W., Han J.S., Jang M., Min S.H., Park J.K., Rowell R.M. Phosphate adsorption on aluminum-impregnated mesoporous silicates: Surface structure and behavior of adsorbents. Environ Sci Technol 2004, 38(3):912-917.
91. 5): Application to phosphoproteomics. Anal Chem 2008, 80(12):4606-4613.
92. Sugiyama N., Masuda T., Shinoda K., Nakamura A., Tomita M., Ishihama Y. Phosphopeptide enrichment by aliphatic hydroxy acid-modified metal oxide chromatography for nano-LC-MS/MS in proteomics applications. Mol Cell Proteomics 2007, 6(6):1103-1109.
93. Kyono Y., Sugiyama N., Imami K., Tomita M., Ishihama Y. Successive and selective release of phosphorylated peptides captured by hydroxy acid-modified metal oxide chromatography. J Proteome Res 2008, 7(10):4585-4593.
94. Thingholm T.E., Jensen O.N., Robinson P.J., Larsen M.R. SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol Cell Proteomics 2008, 7(4):661-671.
95. Salih E. Phosphoproteomics by mass spectrometry and classical protein chemistry approaches. Mass Spectrom Rev 2005, 24(6):828-846.
96. Grimsrud P.A., Swaney D.L., Wenger C.D., Beauchene N.A., Coon J.J. Phosphoproteomics for the masses. ACS Chem Biol 2010, 5(1):105-119.
97. Nita-Lazar A., Saito-Benz H., White F.M. Quantitative phosphoproteomics by mass spectrometry: past, present, and future. Proteomics 2008, 8(21):4433-4443.
98. Boersema P.J., Mohammed S., Heck A.J. Phosphopeptide fragmentation and analysis by mass spectrometry. J Mass Spectrom 2009, 44(6):861-878.
99. Bakalarski C.E., Haas W., Dephoure N.E., Gygi S.P. The effects of mass accuracy, data acquisition speed, and search algorithm choice on peptide identification rates in phosphoproteomics. Anal Bioanal Chem 2007, 389(5):1409-1419.
100. Blackburn K., Goshe M.B. Challenges and strategies for targeted phosphorylation site identification and quantification using mass spectrometry analysis. Brief Funct Genomic Proteomic 2009, 8(2):90-103.
101. Sleno L., Volmer D.A. Ion activation methods for tandem mass spectrometry. J Mass Spectrom 2004, 39(10):1091-1112.
102. Wells J.M., McLuckey S.A. Collision-induced dissociation (CID) of peptides and proteins. Methods Enzymol 2005, 402:148-185.
103. Hunt D.F., Yates J.R., Shabanowitz J., Winston S., Hauer C.R. Protein sequencing by tandem mass spectrometry. Proc Natl Acad Sci U S A 1986, 83(17):6233-6237.
104. Ruse C.I., Tan F.L., Kinter M., Bond M. Intregrated analysis of the human cardiac transcriptome, proteome and phosphoproteome. Proteomics 2004, 4(5):1505-1516.
105. Palumbo A.M., Tepe J.J., Reid G.E. Mechanistic insights into the multistage gas-phase fragmentation behavior of phosphoserine- and phosphothreonine-containing peptides. J Proteome Res 2008, 7(2):771-779.
106. DeGnore J.P., Qin J. Fragmentation of phosphopeptides in an ion trap mass spectrometer. J Am Soc Mass Spectrom 1998, 9(11):1175-1188.
107. Schroeder M.J., Shabanowitz J., Schwartz J.C., Hunt D.F., Coon J.J. A neutral loss activation method for improved phosphopeptide sequence analysis by quadrupole ion trap mass spectrometry. Anal Chem 2004, 76(13):3590-3598.
108. Palmisano G., Sardanelli A.M., Signorile A., Papa S., Larsen M.R. The phosphorylation pattern of bovine heart complex I subunits. Proteomics 2007, 7(10):1575-1583.
109. Villen J., Beausoleil S.A., Gygi S.P. Evaluation of the utility of neutral-loss-dependent MS3 strategies in large-scale phosphorylation analysis. Proteomics 2008, 8(21):4444-4452.
110. Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J., et al. Large-scale phosphorylation analysis of alpha-factor-arrested Saccharomyces cerevisiae. J Proteome Res 2007, 6(3):1190-1197.
111. 3 methodologies for phosphopeptide identification. J Proteome Res 2009, 8(2):887-899.
112. Syka J.E., Coon J.J., Schroeder M.J., Shabanowitz J., Hunt D.F. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci U S A 2004, 101(26):9528-9533.
113. Mikesh L.M., Ueberheide B., Chi A., Coon J.J., Syka J.E., Shabanowitz J., et al. The utility of ETD mass spectrometry in proteomic analysis. Biochim Biophys Acta 2006, 1764(12):1811-1822.
114. Kleinnijenhuis A.J., Kjeldsen F., Kallipolitis B., Haselmann K.F., Jensen O.N. Analysis of histidine phosphorylation using tandem MS and ion - electron reactions. Anal Chem 2007, 79(19):7450-7456.
115. Stensballe A., Jensen O.N., Olsen J.V., Haselmann K.F., Zubarev R.A. Electron capture dissociation of singly and multiply phosphorylated peptides. Rapid Commun Mass Spectrom 2000, 14(19):1793-1800.
116. 2*. Anal Chem 2005, 77(6):1831-1839.
117. Good D.M., Wirtala M., McAlister G.C., Coon J.J. Performance characteristics of electron transfer dissociation mass spectrometry. Mol Cell Proteomics 2007, 6(11):1942-1951.
118. Lu H.J., Zong C.G., Wang Y.J., Young G.W., Deng N., Souda P., et al. Revealing the dynamics of the 20S proteasome phosphoproteome: a combined CID and electron transfer dissociation approach. Mol Cell Proteomics 2008, 7(11):2073-2089.
119. Zong C., Young G.W., Wang Y., Lu H., Deng N., Drews O., et al. Two-dimensional electrophoresis-based characterization of post-translational modifications of mammalian 20S proteasome complexes. Proteomics 2008, 8(23-24):5025-5037.
120. Deng N., Zhang J., Zong C., Wang Y., Lu H., Yang P., et al. Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. Mol Cell Proteomics 2010, 10(2). [M110 000117].
121. Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci U S A 2007, 104(7):2199-2204.
122. Swaney D.L., McAlister G.C., Coon J.J. Decision tree-driven tandem mass spectrometry for shotgun proteomics. Nat Methods 2008, 5(11):959-964.
123. Sweet S.M.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J. Large scale localization of protein phosphorylation by use of electron capture dissociation mass spectrometry. Mol Cell Proteomics 2009, 8(5):904-912.
124. Swaney D.L., McAlister G.C., Wirtala M., Schwartz J.C., Syka J.E.P., Coon J.J. Supplemental activation method for high-efficiency electron-transfer dissociation of doubly protonated peptide precursors. Anal Chem 2007, 79(2):477-485.
125. Chalkley R.J., Baker P.R., Medzihradszky K.F., Lynn A.J., Burlingame A.L. In-depth analysis of tandem mass spectrometry data from disparate instrument types. Mol Cell Proteomics 2008, 7(12):2386-2398.
126. Ma B., Zhang K.Z., Hendrie C., Liang C.Z., Li M., Doherty-Kirby A., et al. PEAKS: powerful software for peptide de novo sequencing by tandem mass spectrometry. Rapid Commun Mass Spectrom 2003, 17(20):2337-2342.
127. Liu X., Shan B., Xin L., Ma B. Better score function for peptide identification with ETD MS/MS spectra. BMC Bioinformatics 2010, 11(Suppl. 1):S4.
128. Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat Biotechnol 2006, 24(10):1285-1292.
129. Bailey C.M., Sweet S.M., Cunningham D.L., Zeller M., Heath J.K., Cooper H.J. SLoMo: automated site localization of modifications from ETD/ECD mass spectra. J Proteome Res 2009, 8(4):1965-1971.
130. Ruttenberg B.E., Pisitkun T., Knepper M.A., Hoffert J.D. PhosphoScore: an open-source phosphorylation site assignment tool for MSn data. J Proteome Res 2008, 7(7):3054-3059.
131. Olsen J.V., Mann M. Improved peptide identification in proteomics by two consecutive stages of mass spectrometric fragmentation. Proc Natl Acad Sci U S A 2004, 101(37):13417-13422.
132. Schwartz D., Gygi S.P. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat Biotechnol 2005, 23(11):1391-1398.
133. Obenauer J.C., Cantley L.C., Yaffe M.B. Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 2003, 31(13):3635-3641.
134. Linding R., Jensen L.J., Pasculescu A., Olhovsky M., Colwill K., Bork P., et al. NetworKIN: a resource for exploring cellular phosphorylation networks. Nucleic Acids Res 2008, 36(Database issue):D695-D699.
135. Wong Y.H., Lee T.Y., Liang H.K., Huang C.M., Wang T.Y., Yang Y.H., et al. KinasePhos 2.0: a web server for identifying protein kinase-specific phosphorylation sites based on sequences and coupling patterns. Nucleic Acids Res 2007, 35(Web Server issue):W588-W594.
136. Huang H.D., Lee T.Y., Tzeng S.W., Horng J.T. KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites. Nucleic Acids Res 2005, 33(Web Server issue):W226-W229.
137. Arrell D.K., Neverova I., Fraser H., Marban E., Van Eyk J.E. Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1. Circ Res 2001, 89(6):480-487.
138. Chu G.X., Egnaczyk G.F., Zhao W., Jo S.H., Fan G.C., Maggio J.E., et al. Phosphoproteome analysis of cardiomyocytes subjected to beta-adrenergic stimulation - Identification and characterization of a cardiac heat shock protein p20. Circ Res 2004, 94(2):184-193.
139. Feng J., Zhu M., Schaub M.C., Gehrig P., Roschitzki B., Lucchinetti E., et al. Phosphoproteome analysis of isoflurane-protected heart mitochondria: phosphorylation of adenine nucleotide translocator-1 on Tyr194 regulates mitochondrial function. Cardiovasc Res 2008, 80(1):20-29.
140. Yuan C., Sheng Q., Tang H., Li Y., Zeng R., Solaro R.J. Quantitative comparison of sarcomeric phosphoproteomes of neonatal and adult rat hearts. Am J Physiol Heart Circ Physiol 2008, 295(2):H647-H656.
141. Oda Y., Huang K., Cross F.R., Cowburn D., Chait B.T. Accurate quantitation of protein expression and site-specific phosphorylation. Proc Natl Acad Sci U S A 1999, 96(12):6591-6596.
142. Wu C.C., MacCoss M.J., Howell K.E., Matthews D.E., Yates J.R. Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis. Anal Chem 2004, 76(17):4951-4959.
143. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 2002, 1(5):376-386.
144. Zhu H.N., Pan S.Q., Gu S., Bradbury E.M., Chen X. Amino acid residue specific stable isotope labeling for quantitative proteomics. Rapid Commun Mass Spectrom 2002, 16(22):2115-2123.
145. Ibarrola N., Kalume D.E., Gronborg M., Iwahori A., Pandey A. A proteomic approach for quantitation of phosphorylation using stable isotope labeling in cell culture. Anal Chem 2003, 75(22):6043-6049.
146. Pan C., Olsen J.V., Daub H., Mann M. Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Mol Cell Proteomics 2009, 8(12):2796-2808.
147. Kruger M., Kratchmarova I., Blagoev B., Tseng Y.H., Kahn C.R., Mann M. Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Proc Natl Acad Sci U S A 2008, 105(7):2451-2456.
148. Cunningham D.L., Sweet S.M., Cooper H.J., Heath J.K. Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events. J Proteome Res 2010, 9(5):2317-2328.
149. Hilger M., Bonaldi T., Gnad F., Mann M. Systems-wide analysis of a phosphatase knock-down by quantitative proteomics and phosphoproteomics. Mol Cell Proteomics 2009, 8(8):1908-1920.
150. Christensen G.L., Kelstrup C.D., Lyngso C., Sarwar U., Bogebo R., Sheikh S.P., et al. Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists. Mol Cell Proteomics 2010, 9(7):1540-1553.
151. Kruger M., Moser M., Ussar S., Thievessen I., Luber C.A., Forner F., et al. SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function. Cell 2008, 134(2):353-364.
152. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004, 3(12):1154-1169.
153. Olsen J.V., Macek B., Lange O., Makarov A., Horning S., Mann M. Higher-energy C-trap dissociation for peptide modification analysis. Nat Methods 2007, 4(9):709-712.
154. Griffin T.J., Xie H., Bandhakavi S., Popko J., Mohan A., Carlis J.V., et al. iTRAQ reagent-based quantitative proteomic analysis on a linear ion trap mass spectrometer. J Proteome Res 2007, 6(11):4200-4209.
155. Coon J.J., Phanstiel D., Unwin R., McAlister G.C. Peptide quantification using 8-plex isobaric tags and electron transfer dissociation tandem mass spectrometry. Anal Chem 2009, 81(4):1693-1698.
156. Coon J.J., Phanstiel D., Zhang Y., Marto J.A. Peptide and protein quantification using iTRAQ with electron transfer dissociation. J Am Soc Mass Spectrom 2008, 19(9):1255-1262.
157. McLuckey S.A., Han H.L., Pappin D.J., Ross P.L. Electron transfer dissociation of iTRAQ labeled peptide ions. J Proteome Res 2008, 7(9):3643-3648.
158. Mischerikow N., van Nierop P., Li K.W., Bernstein H.G., Smit A.B., Heck A.J., et al. Gaining efficiency by parallel quantification and identification of iTRAQ-labeled peptides using HCD and decision tree guided CID/ETD on an LTQ Orbitrap. Analyst 2010, 135(10):2643-2652.
159. Yang F., Wu S., Stenoien D.L., Zhao R., Monroe M.E., Gritsenko M.A., et al. Combined pulsed-Q dissociation and electron transfer dissociation for identification and quantification of iTRAQ-labeled phosphopeptides. Anal Chem 2009, 81(10):4137-4143.
160. Williamson B.L., Ross P.L., Pillai S., Purkayastha B., Daniels S., Pappin D. Protein quantitation using a novel 8-plex set of isobaric peptide labels. Mol Cell Proteomics 2006, 5(10):S55-S.
161. Thompson A., Schafer J., Kuhn K., Kienle S., Schwarz J., Schmidt G., et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem 2003, 75(8):1895-1904.
162. Nilsson C.L., Dillon R., Devakumar A., Shi S.D., Greig M., Rogers J.C., et al. Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells. J Proteome Res 2010, 9(1):430-443.
163. Mirgorodskaya O.A., Kozmin Y.P., Titov M.I., Korner R., Sonksen C.P., Roepstorff P. Quantitation of peptides and proteins by matrix-assisted laser desorption/ionization mass spectrometry using O-18-labeled internal standards. Rapid Commun Mass Spectrom 2000, 14(14):1226-1232.
164. 18O labeling. Physiol Genomics 2007, 31(2):357-363.
165. Wang Y., Ding S.J., Wang W., Jacobs J.M., Qian W.J., Moore R.J., et al. Profiling signaling polarity in chemotactic cells. Proc Natl Acad Sci U S A 2007, 104(20):8328-8333.
166. Yang F., Jaitly N., Jayachandran H., Luo Q., Monroe M.E., Du X., et al. Applying a targeted label-free approach using LC-MS AMT tags to evaluate changes in protein phosphorylation following phosphatase inhibition. J Proteome Res 2007, 6(11):4489-4497.
167. Cao L., Yu K., Banh C., Nguyen V., Ritz A., Raphael B.J., et al. Quantitative time-resolved phosphoproteomic analysis of mast cell signaling. J Immunol 2007, 179(9):5864-5876.
168. Xie X., Feng S., Vuong H., Liu Y., Goodison S., Lubman D.M. A comparative phosphoproteomic analysis of a human tumor metastasis model using a label-free quantitative approach. Electrophoresis 2010, 31(11):1842-1852.
169. Old W.M., Meyer-Arendt K., Aveline-Wolf L., Pierce K.G., Mendoza A., Sevinsky J.R., et al. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics 2005, 4(10):1487-1502.
170. Zybailov B., Coleman M.K., Florens L., Washburn M.P. Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Anal Chem 2005, 77(19):6218-6224.
171. Gerber S.A., Rush J., Stemman O., Kirschner M.W., Gygi S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A 2003, 100(12):6940-6945.
172. Wu R., Haas W., Dephoure N., Huttlin E.L., Zhai B., Sowa M.E., et al. A large-scale method to measure absolute protein phosphorylation stoichiometries. Nat Methods 2011, 8(8):677-683.
173. Bueno O.F., De Windt L.J., Tymitz K.M., Witt S.A., Kimball T.R., Klevitsky R., et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 2000, 19(23):6341-6350.
174. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000, 101(4):365-376.
175. Antos C.L., Frey N., Marx S.O., Reiken S., Gaburjakova M., Richardson J.A., et al. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. Circ Res 2001, 89(11):997-1004.
176. 2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ Res 1999, 84(6):713-721.
177. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93(2):215-228.
178. Wilkins B.J., Molkentin J.D. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 2004, 322(4):1178-1191.
179. Takeishi Y., Abe J., Lee J.D., Kawakatsu H., Walsh R.A., Berk B.C. Differential regulation of p90 ribosomal S6 kinase and big mitogen-activated protein kinase 1 by ischemia/reperfusion and oxidative stress in perfused guinea pig hearts. Circ Res 1999, 85(12):1164-1172.
180. Devary Y., Gottlieb R.A., Smeal T., Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 1992, 71(7):1081-1091.
181. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001, 81(2):807-869.
182. Pombo C.M., Bonventre J.V., Avruch J., Woodgett J.R., Kyriakis J.M., Force T.L. The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem 1994, 269(42):26546-26551.
183. Lee J.C., Kumar S., Griswold D.E., Underwood D.C., Votta B.J., Adams J.L. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 2000, 47(2-3):185-201.
184. Gao F., Yue T.L., Shi D.W., Christopher T.A., Lopez B.L., Ohlstein E.H., et al. P38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. Cardiovasc Res 2002, 53(2):414-422.
185. Clanachan A.S., Jaswal J.S., Gandhi M., Bottorff D.A., Coughlin J., Finegan B.A., et al. Effects of inhibition of myocardial extracellular-responsive kinase and P38 mitogen-activated protein kinase on mechanical function of rat hearts after prolonged hypothermic ischemia. Transplantation 2003, 75(2):173-180.
186. Harding S.E., Brown L.A., Wynne D.G., Davies C.H., Poole-Wilson P.A. Mechanisms of beta adrenoceptor desensitisation in the failing human heart. Cardiovasc Res 1994, 28(10):1451-1460.
187. Pieske B., Beyermann B., Breu V., Loffler B.M., Schlotthauer K., Maier L.S., et al. Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 1999, 99(14):1802-1809.
188. Asano K., Dutcher D.L., Port J.D., Minobe W.A., Tremmel K.D., Roden R.L., et al. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation 1997, 95(5):1193-1200.
189. Takeishi Y., Bhagwat A., Ball N.A., Kirkpatrick D.L., Periasamy M., Walsh R.A. Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failure. Am J Physiol 1999, 276(1 Pt 2):H53-H62.
190. Xuan Y.T., Guo Y., Han H., Zhu Y., Bolli R. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci U S A 2001, 98(16):9050-9055.
191. Harada M., Qin Y., Takano H., Minamino T., Zou Y., Toko H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005, 11(3):305-311.
192. Boengler K., Hilfiker-Kleiner D., Drexler H., Heusch G., Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther 2008, 120(2):172-185.
193. Negoro S., Kunisada K., Tone E., Funamoto M., Oh H., Kishimoto T., et al. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res 2000, 47(4):797-805.
194. Bhuiyan M.S., Shioda N., Fukunaga K. Targeting protein kinase B/Akt signaling with vanadium compounds for cardioprotection. Expert Opin Ther Targets 2008, 12(10):1217-1227.
195. Yao Y., Li L., Gao C., Shi C. Sevoflurane postconditioning protects chronically-infarcted rat hearts against ischemia-reperfusion injury by activation of pro-survival kinases and inhibition of mitochondrial permeability transition pore opening upon reperfusion. Biol Pharm Bull 2009, 32(11):1854-1861.
196. Matsui T., Tao J., del Monte F., Lee K.H., Li L., Picard M., et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001, 104(3):330-335.
197. Ping P., Song C., Zhang J., Guo Y., Cao X., Li R.C.X., et al. Formation of protein kinase Cε-Lck signaling modules confers cardioprotection. J Clin Invest 2002, 109(4):499-507.
198. Ping P., Zhang J., Pierce W.M., Bolli R. Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ Res 2001, 88(1):59-62.
199. Li R.C., Ping P., Zhang J., Wead W.B., Cao X., Gao J., et al. PKCε modulates NF-κB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol 2000, 279(4):H1679-H1689.
200. Bolli R. The late phase of preconditioning. Circ Res 2000, 87(11):972-983.
201. Ping P., Zhang J., Cao X., Li R.C., Kong D., Tang X.L., et al. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol 1999, 276(5 Pt 2):H1468-H1481.
202. Ping P., Takano H., Zhang J., Tang X.-L., Qiu Y., Li R.C., et al. Isoform-selective activation of protein kinase c by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res 1999, 84(5):587-604.
203. Liu G.S., Cohen M.V., Mochly-Rosen D., Downey J.M. Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 1999, 31(10):1937-1948.
204. Ping P., Zhang J., Qiu Y., Tang X.-L., Manchikalapudi S., Cao X., et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 1997, 81(3):404-414.
205. Gray M.O., Karliner J.S., Mochly-Rosen D. A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 1997, 272(49):30945-30951.
206. Hausenloy D.J., Tsang A., Mocanu M.M., Yellon D.M. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 2005, 288(2):H971-H976.
207. Hausenloy D.J., Tsang A., Yellon D.M. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 2005, 15(2):69-75.
208. Hausenloy D.J., Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004, 61(3):448-460.
209. Zhang M., Kass D.A. Phosphodiesterases and cardiac cGMP: evolving roles and controversies. Trends Pharmacol Sci 2011, 32(6):360-365.
210. Layland J., Solaro R.J., Shah A.M. Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovasc Res 2005, 66(1):12-21.
211. Zhang R., Zhao J., Mandveno A., Potter J.D. Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ Res 1995, 76(6):1028-1035.
212. van der Velden J., Papp Z., Zaremba R., Boontje N.M., de Jong J.W., Owen V.J., et al. Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc Res 2003, 57(1):37-47.
213. Copeland O., Sadayappan S., Messer A.E., Steinen G.J., van der Velden J., Marston S.B. Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle. J Mol Cell Cardiol 2010, 49(6):1003-1011.
214. Carrier L. Cardiac myosin-binding protein C in the heart. Arch Mal Coeur Vaiss 2007, 100(3):238-243.
215. Machackova J., Barta J., Dhalla N.S. Myofibrillar remodelling in cardiac-hypertrophy, heart failure and cardiomyopathies. Can J Cardiol 2006, 22(11):953-968.
216. Phrommintikul A., Chattipakorn N. Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death. Int J Cardiol 2006, 112(2):142-152.
217. Kushnir A., Marks A.R. The ryanodine receptor in cardiac physiology and disease. Adv Pharmacol 2010, 59:1-30.
218. Treinys R., Jurevicius J. L-type Ca2+ channels in the heart: structure and regulation. Medicina (Kaunas) 2008, 44(7):491-499.
219. Marx S.O., Kurokawa J., Reiken S., Motoike H., D'Armiento J., Marks A.R., et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 2002, 295(5554):496-499.
220. Hulme J.T., Scheuer T., Catterall W.A. Regulation of cardiac ion channels by signaling complexes: role of modified leucine zipper motifs. J Mol Cell Cardiol 2004, 37(3):625-631.
221. Vlahos C.J., McDowell S.A., Clerk A. Kinases as therapeutic targets for heart failure. Nat Rev Drug Discov 2003, 2(2):99-113.
222. Force T., Kuida K., Namchuk M., Parang K., Kyriakis J.M. Inhibitors of protein kinase signaling pathways: emerging therapies for cardiovascular disease. Circulation 2004, 109(10):1196-1205.
223. Edmondson R.D., Vondriska T.M., Biederman K.J., Zhang J., Jones R.C., Zheng Y., et al. Protein kinase C epsilon signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS. Mol Cell Proteomics 2002, 1(6):421-433.
224. Chou H.C., Chen Y.W., Lee T.R., Wu F.S., Chan H.T., Lyu P.C., et al. Proteomics study of oxidative stress and Src kinase inhibition in H9C2 cardiomyocytes: a cell model of heart ischemia-reperfusion injury and treatment. Free Radic Biol Med 2010, 49(1):96-108.
225. Fernando P., Deng W., Pekalska B., DeRepentigny Y., Kothary R., Kelly J.F., et al. Active kinase proteome screening reveals novel signal complexity in cardiomyopathy. Mol Cell Proteomics 2005, 4(5):673-682.
226. Tian R., Musi N., D'Agostino J., Hirshman M.F., Goodyear L.J. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 2001, 104(14):1664-1669.
227. Satoh S., Ueda Y., Koyanagi M., Kadokami T., Sugano M., Yoshikawa Y., et al. Chronic inhibition of Rho kinase blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension-induced heart failure. J Mol Cell Cardiol 2003, 35(1):59-70.
228. Morissette M.R., Sah V.P., Glembotski C.C., Brown J.H. The Rho effector, PKN, regulates ANF gene transcription in cardiomyocytes through a serum response element. Am J Physiol Heart Circ Physiol 2000, 278(6):H1769-H1774.
229. Morrison A.C., Doris P.A., Folsom A.R., Nieto F.J., Boerwinkle E., Hegele R.A. G-protein beta 3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke 2001, 32(4):822-829.
230. Toyofuku T., Zhang H., Kumanogoh A., Takegahara N., Yabuki M., Harada K., et al. Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling. Nat Cell Biol 2004, 6(12):1204-1211.
231. Paulsson A.K., Franklin S., Mitchell-Jordan S.A., Ren S., Wang Y., Vondriska T.M. Post-translational regulation of calsarcin-1 during pressure overload-induced cardiac hypertrophy. J Mol Cell Cardiol 2010, 48(6):1206-1214.
232. Aplin M., Christensen G.L., Hansen J.L. Pharmacologic perspectives of functional selectivity by the angiotensin II type 1 receptor. Trends Cardiovasc Med 2008, 18(8):305-312.
233. Newmeyer D.D., Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 2003, 112(4):481-490.
234. Frohman M.A. Mitochondria as integrators of signal transduction and energy production in cardiac physiology and disease. J Mol Med (Berl) 2010, 88(10):967-970.
235. Horbinski C., Chu C.T. Kinase signaling cascades in the mitochondrion: a matter of life or death. Free Radic Biol Med 2005, 38(1):2-11.
236. Schulenberg B., Aggeler R., Beechem J.M., Capaldi R.A., Patton W.F. Analysis of steady-state protein phosphorylation in mitochondria using a novel fluorescent phosphosensor dye. J Biol Chem 2003, 278(29):27251-27255.
237. Yin X., Cuello F., Mayr U., Hao Z., Hornshaw M., Ehler E., et al. Proteomics analysis of the cardiac myofilament subproteome reveals dynamic alterations in phosphatase subunit distribution. Mol Cell Proteomics 2010, 9(3):497-509.
238. Zong C., Gomes A.V., Drews O., Li X., Young G.W., Berhane B., et al. Regulation of murine cardiac 20S proteasomes: role of associating partners. Circ Res 2006, 99(4):372-380.
239. Lu H., Zong C., Wang Y., Young G.W., Deng N., Souda P., et al. Revealing the dynamics of the 20 S proteasome phosphoproteome: a combined CID and electron transfer dissociation approach. Mol Cell Proteomics 2008, 7(11):2073-2089.
240. Dubois E., Richard V., Mulder P., Lamblin N., Drobecq H., Henry J.P., et al. Decreased Serine(207) phosphorylation of troponin T as a biomarker for left ventricular remodelling after myocardial infarction. Eur Heart J 2011, 32(1):115-123.
241. Yu W., Taylor J.A., Davis M.T., Bonilla L.E., Lee K.A., Auger P.L., et al. Maximizing the sensitivity and reliability of peptide identification in large-scale proteomic experiments by harnessing multiple search engines. Proteomics 2010, 10(6):1172-1189.
242. Goldstrohm D.A., Broeckling C.D., Prenni J.E., Curthoys N.P. Importance of manual validation for the identification of phosphopeptides using a linear ion trap mass spectrometer. J Biomol Tech 2011, 22(1):10-20.